Home
Learn More
Release Features
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
May 15, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
 
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for June 23, 2002 Subscribe to this News Feed      
 

REJUVENA TEAMS WITH INTERNATIONALLY ACCLAIMED CELL BIOLOGIST TO LAUNCH PSORIASIS, SKIN DISEASE CREAM

Miraderm Psoriasis Cream is a patent-pending, nonprescription topical lotion that has been proven to treat psoriasis in clinical trials. Miraderm is also effective in treating eczema, dermatitis, dandruff, seborrheic dermatitis and inflammatory skin lesions.

MEDIA CONTACTS:               Steve Roth & Jane Cohen      
InterStar Marketing & PR   
(817) 332-6522   

REJUVENA TEAMS WITH INTERNATIONALLY ACCLAIMED CELL BIOLOGIST
TO LAUNCH PSORIASIS, SKIN DISEASE CREAM

FORT WORTH, Texas (June 21, 2002) Rejuvena Distribution has teamed with renowned cell biologist Dr. Lorraine Meisner to market a line of skin care products to successfully treat psoriasis and other skin diseases.

Miraderm Psoriasis Cream is a patent-pending, nonprescription topical lotion that has been proven to treat psoriasis in clinical trials. Miraderm is also effective in treating eczema, dermatitis, dandruff, seborrheic dermatitis and inflammatory skin lesions. Other products will be available soon.

"We're excited to introduce this cream internationally to the millions of people who suffer from the agonizing symptoms of psoriasis," said Brenda Warren, principal of Rejuvena Distribution, the exclusive distributor for Miraderm. "Miraderm Psoriasis Cream has produced dramatic improvement in patients who have had limited or no success with other treatments - and it has none of the usual side effects."

Dr. Lorraine Meisner is a pioneer of vitamin C anti-aging creams, and her anti-aging products are sold worldwide. Dr. Meisner has been a professor at the University of Wisconsin - Madison Medical School since 1968. She has held other positions at prestigious institutions such as Stanford University, Dept. of Medicine; University of Virginia Medical School; Cancer Research Institute in Boston; and Chief, Cytogenetics Section of the State Laboratory of Hygiene (Wisconsin). Miraderm Psoriasis Cream is her latest invention. The cream combines the rigors of science and research with the use of natural products to provide relief for red, itchy skin.

"With most therapies for psoriasis there are severe side effects," Dr. Meisner said. "Some may cause cancer and others cause skin to thin out. Most products work because they shut down the immune system. Miraderm Psoriasis Cream doesn't do that. It has a natural, herbal base. I don't like to mess with Mother Nature."

Psoriasis is a chronic skin disorder that is believed to be related to the immune system, though the cause is still unknown. It is not contagious; a person cannot "catch" psoriasis from another person. No cure has been found for psoriasis.

"Miraderm Psoriasis Cream can be used frequently, as opposed to a steroid," Meisner said. "And once it goes away, you don't have to use the cream anymore. With steroids, as soon as you stop, the psoriasis comes back. Miraderm helps improve the integrity of the skin making it difficult for the T-cells - which cause the lesions - to take hold."

Rejuvena has launched its Web site (www.rejuvena.net) as an informational clearinghouse on psoriasis and other skin diseases. Miraderm Psoriasis Cream sells for $22.95 for a 50 ml tube or $39.95 for a 100 ml tube. Volume discounts are available. Contact Rejuvena toll free at 1-866-Miraderm (1-866-647-2336).

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Steve Roth
Interstar
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright